A detailed history of Cwm, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Cwm, LLC holds 103 shares of LQDA stock, worth $1,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103
Previous 308 66.56%
Holding current value
$1,189
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$8.9 - $14.11 $1,824 - $2,892
-205 Reduced 66.56%
103 $1,000
Q2 2024

Jul 09, 2024

BUY
$11.96 - $15.71 $1,674 - $2,199
140 Added 83.33%
308 $4,000
Q1 2024

Apr 05, 2024

BUY
$11.35 - $16.73 $1,906 - $2,810
168 New
168 $2,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $743M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.